Effects of GS-CA1 on nuclear envelope-associated early HIV-1 infection steps
The novel HIV-1 drugs GS-CA1 and the recently approved lenacapavir (GS-6207) target the viral structural protein capsid (CA). However, their multiple mechanisms of action have not been fully characterized. Here, we investigated the effects of GS-CA1 on the early stages of HIV-1 infection, specifical...
Saved in:
Main Authors: | Amita Singh, Victor Fourcassié, Karen Cristine Gonçalves Dos Santos, Hocine Chelbi, Natacha Merindol, Arnaud Droit, Hugo Germain, Lionel Berthoux |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Virology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fviro.2025.1547176/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From the Cytoplasm into the Nucleus—Hepatitis B Virus Travel and Genome Repair
by: Johan Ringlander, et al.
Published: (2025-01-01) -
Nuclear envelope components in vascular mechanotransduction: emerging roles in vascular health and disease
by: Tung D. Nguyen, et al.
Published: (2025-12-01) -
C-28 linker length modulates the activity of second-generation HIV-1 maturation inhibitors
by: K. C. Yuvraj, et al.
Published: (2025-01-01) -
Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal
by: Shreyal Maikoo, et al.
Published: (2024-12-01) -
The Proviral Reservoirs of Human Immunodeficiency Virus (HIV) Infection
by: Andrey I. Murzin, et al.
Published: (2024-12-01)